HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Niklas Feldhahn Selected Research

Pre-B Cell Receptors

9/2005Deficiency of Bruton's tyrosine kinase in B cell precursor leukemia cells.
6/2005Mimicry of a constitutively active pre-B cell receptor in acute lymphoblastic leukemia cells.
3/2004The BCR-ABL1 kinase bypasses selection for the expression of a pre-B cell receptor in pre-B acute lymphoblastic leukemia cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Niklas Feldhahn Research Topics

Disease

10Leukemia
01/2017 - 03/2004
7Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
08/2012 - 03/2004
5Neoplasms (Cancer)
01/2021 - 07/2004
3Lymphoma (Lymphomas)
02/2013 - 10/2007
2Ataxia Telangiectasia (Louis Bar Syndrome)
02/2013 - 04/2010
2Genomic Instability
10/2012 - 05/2011
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
09/2009 - 10/2007
2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell)
01/2005 - 03/2004
1Inflammation (Inflammations)
01/2018
1Hypersensitivity (Allergy)
04/2010
1B-Cell Lymphoma (Lymphoma, B Cell)
11/2009
1Blast Crisis (Blast Phase)
09/2009
1Infections
04/2009
1Philadelphia Chromosome
05/2007

Drug/Important Bio-Agent (IBA)

7DNA (Deoxyribonucleic Acid)IBA
01/2017 - 11/2009
7Phosphotransferases (Kinase)IBA
10/2007 - 03/2004
5Imatinib Mesylate (Gleevec)FDA Link
09/2009 - 03/2004
3Cytidine DeaminaseIBA
02/2013 - 05/2007
3Pre-B Cell ReceptorsIBA
09/2005 - 03/2004
2Proteins (Proteins, Gene)FDA Link
01/2019 - 12/2004
2Pharmaceutical PreparationsIBA
08/2012 - 08/2012
2nilotinibFDA Link
08/2012 - 10/2007
2Immunoglobulins (Immunoglobulin)IBA
11/2009 - 04/2009
2Antigen Receptors (Antigen Receptor)IBA
07/2004 - 03/2004
1Telomerase (Telomerase Reverse Transcriptase)IBA
01/2021
1Glutamine (L-Glutamine)FDA Link
01/2019
1Glucose (Dextrose)FDA LinkGeneric
01/2019
1CateninsIBA
01/2018
1Tumor Suppressor p53-Binding Protein 1IBA
02/2013
1DNA-Binding Proteins (DNA Binding Protein)IBA
10/2012
1lonafarnib (SCH 66336)IBA
08/2012
1Farnesyltranstransferase (Farnesyltransferase)IBA
08/2012
1Tyrosine Kinase InhibitorsIBA
08/2012
1Single-Stranded DNA (DNA, Single Stranded)IBA
04/2010
1DNA Ligases (Ligases, DNA)IBA
04/2010
1MicroRNAs (MicroRNA)IBA
11/2009
11,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
11/2009
1GP 140IBA
04/2009
1AntibodiesIBA
04/2009
1EpitopesIBA
04/2009
1Membrane Proteins (Integral Membrane Proteins)IBA
04/2009
1bcr-abl Fusion ProteinsIBA
10/2007
1Agammaglobulinaemia Tyrosine KinaseIBA
09/2005
1Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
09/2005
1IgKIBA
01/2005
1Transcription Factors (Transcription Factor)IBA
01/2005
1Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
03/2004

Therapy/Procedure

2Therapeutics
10/2007 - 07/2004
1Aftercare (After-Treatment)
03/2004